201 related articles for article (PubMed ID: 34145993)
1. Levosimendan in venoarterial ECMO weaning. Rational and design of a randomized double blind multicentre trial.
Ellouze O; Soudry Faure A; Radhouani M; Abou-Arab O; Besnier E; Moussa M; Cransac A; Ksiazek E; Fischer MO; Mertes PM; Bouhemad B; Guinot PG
ESC Heart Fail; 2021 Aug; 8(4):3339-3347. PubMed ID: 34145993
[TBL] [Abstract][Full Text] [Related]
2. Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis.
Guilherme E; Jacquet-Lagrèze M; Pozzi M; Achana F; Armoiry X; Fellahi JL
Crit Care; 2020 Jul; 24(1):442. PubMed ID: 32677985
[TBL] [Abstract][Full Text] [Related]
3. Early Levosimendan Administration Improved Weaning Success Rate in Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock.
Chen YW; Lee WC; Wu PJ; Fang HY; Fang YN; Chen HC; Tong MS; Sung PH; Lee CH; Chung WJ
Front Cardiovasc Med; 2022; 9():912321. PubMed ID: 35845047
[TBL] [Abstract][Full Text] [Related]
4. The Effectiveness of Levosimendan on Veno-Arterial Extracorporeal Membrane Oxygenation Management and Outcome: A Systematic Review and Meta-Analysis.
Kaddoura R; Omar AS; Ibrahim MIM; Alkhulaifi A; Lorusso R; Elsherbini H; Soliman O; Caliskan K
J Cardiothorac Vasc Anesth; 2021 Aug; 35(8):2483-2495. PubMed ID: 33583718
[TBL] [Abstract][Full Text] [Related]
5. Short-term effects of levosimendan use for venoarterial extracorporeal membrane oxygenation: A systematic review and meta-analysis.
Yang B; Zhao T; Guo B; Li Y
Perfusion; 2023 Mar; 38(2):305-312. PubMed ID: 34689640
[TBL] [Abstract][Full Text] [Related]
6. Effects of levosimendan on the outcome of veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis.
Liu Y; Zhang L; Yao Y; Li Y; Qin W; Li Y; Xue W; Li P; Chen Y; Chen X; Guo H
Clin Res Cardiol; 2024 Apr; 113(4):509-521. PubMed ID: 37217802
[TBL] [Abstract][Full Text] [Related]
7. Levosimendan in veno-arterial extracorporeal membrane oxygenator supported patients: Impact on the success of weaning and survival.
Alonso-Fernandez-Gatta M; Merchan-Gomez S; Gonzalez-Cebrian M; Diego-Nieto A; Alzola E; Toranzo-Nieto I; Barrio A; Martin-Herrero F; Sanchez PL
Artif Organs; 2021 Jul; 45(7):717-725. PubMed ID: 33377185
[TBL] [Abstract][Full Text] [Related]
8. Levosimendan in patients undergoing extracorporeal membrane oxygenation after cardiac surgery: an emulated target trial using observational data.
Massol J; Simon-Tillaux N; Tohme J; Hariri G; Dureau P; Duceau B; Belin L; Hajage D; De Rycke Y; Charfeddine A; Lebreton G; Combes A; Bouglé A
Crit Care; 2023 Feb; 27(1):51. PubMed ID: 36750852
[TBL] [Abstract][Full Text] [Related]
9. Levosimendan may improve weaning outcomes in venoarterial ECMO patients.
Affronti A; di Bella I; Carino D; Ragni T
ASAIO J; 2013; 59(6):554-7. PubMed ID: 24172260
[TBL] [Abstract][Full Text] [Related]
10. Levosimendan's effect on venoarterial extracorporeal membrane oxygenation weaning.
Hau M; Fong KM; Au SY
Int J Artif Organs; 2022 Jun; 45(6):571-579. PubMed ID: 35570732
[TBL] [Abstract][Full Text] [Related]
11. Prevention and treatment of pulmonary congestion in patients undergoing venoarterial extracorporeal membrane oxygenation for cardiogenic shock.
Lüsebrink E; Orban M; Kupka D; Scherer C; Hagl C; Zimmer S; Luedike P; Thiele H; Westermann D; Massberg S; Schäfer A; Orban M
Eur Heart J; 2020 Oct; 41(38):3753-3761. PubMed ID: 33099278
[TBL] [Abstract][Full Text] [Related]
12. Role of levosimendan in weaning children requiring veno-arterial extracorporeal membrane oxygenation after cardiac surgery.
Pan KC; Shankar S; Millar J; Chiletti R; Butt W; d'Udekem Y; Namachivayam SP
Eur J Cardiothorac Surg; 2021 Jan; 59(1):262-268. PubMed ID: 32910173
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of levosimendan to wean patients from VA-ECMO: a systematic review and meta-analysis.
Bertini P; Paternoster G; Landoni G; Falcone M; Nocci M; Costanzo D; Brizzi G; Romani M; Esposito A; Guarracino F
Minerva Cardiol Angiol; 2023 Oct; 71(5):564-574. PubMed ID: 35687316
[TBL] [Abstract][Full Text] [Related]
14. Protocol for a multicentre randomised controlled trial evaluating the effects of moderate hypothermia versus normothermia on mortality in patients with refractory cardiogenic shock rescued by venoarterial extracorporeal membrane oxygenation (VA-ECMO) (HYPO-ECMO study).
Jacquot A; Lepage X; Merckle L; Girerd N; Levy B
BMJ Open; 2019 Oct; 9(10):e031697. PubMed ID: 31615800
[TBL] [Abstract][Full Text] [Related]
15. Impact of levosimendan on weaning from peripheral venoarterial extracorporeal membrane oxygenation in intensive care unit.
Vally S; Ferdynus C; Persichini R; Bouchet B; Braunberger E; Lo Pinto H; Martinet O; Vandroux D; Aujoulat T; Allyn J; Allou N
Ann Intensive Care; 2019 Feb; 9(1):24. PubMed ID: 30707314
[TBL] [Abstract][Full Text] [Related]
16. Effects of levosimendan on weaning and survival in adult cardiogenic shock patients with veno-arterial extracorporeal membrane oxygenation: systematic review and meta-analysis.
Burgos LM; Seoane L; Furmento JF; Costabel JP; Diez M; Vrancic M; Aissaoui N; Benzadón MN; Navia D
Perfusion; 2020 Sep; 35(6):484-491. PubMed ID: 32449494
[TBL] [Abstract][Full Text] [Related]
17. Mechanical support with venoarterial extracorporeal membrane oxygenation (ECMO-VA): Short-term and long-term prognosis after a successful weaning.
García-Gigorro R; Renes-Carreño E; Pérez-Vela JL; Marín-Mateos H; Gutiérrez J; Corrés-Peiretti MA; Delgado JF; Pérez-de la Sota E; Cortina-Romero JM; Montejo-González JC
Med Intensiva; 2017 Dec; 41(9):513-522. PubMed ID: 28259366
[TBL] [Abstract][Full Text] [Related]
18. The impact of levosimendan on survival and weaning from ECMO after extracorporeal cardiopulmonary resuscitation.
Gaisendrees C; Schlachtenberger G; Gerfer S; Krasivskyi I; Djordjevic I; Sabashnikov A; Kosmopoulos M; Jaeger D; Luehr M; Kuhn E; Deppe AC; Wahlers T
Artif Organs; 2023 Aug; 47(8):1351-1360. PubMed ID: 37032531
[TBL] [Abstract][Full Text] [Related]
19. Venoarterial extracorporeal membrane oxygenation in cardiogenic shock: indications, mode of operation, and current evidence.
Pineton de Chambrun M; Bréchot N; Combes A
Curr Opin Crit Care; 2019 Aug; 25(4):397-402. PubMed ID: 31116109
[TBL] [Abstract][Full Text] [Related]
20. Weaning adult patients with cardiogenic shock on veno-arterial extracorporeal membrane oxygenation by pump-controlled retrograde trial off.
Ling L; Chan KM
Perfusion; 2018 Jul; 33(5):339-345. PubMed ID: 29409389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
